Shi J, et al. - Investigators in this study analyzed the relationship between EGFR mutations and visceral pleural invasion (VPI) along with the prognostic value of EGFR in resected non-small-cell lung cancer (NSCLC) cases with VPI. They detected VPI and EGFR mutations in 229 and 243 cases in NSCLC, respectively. They reported a significant correlation between GFR mutations and VPI development in NSCLC. No significant relationship was observed between EGFR mutations and disease-free survival (DFS) in candidates with VPI.